Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2019

Aug 1, 2019

29809_dirs_2019-07-31_6172bc54-249b-4523-827d-7e464c16ba38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2019-07-29

Reporting Person: MOHR MARSHALL (Executive VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-29 Common Stock M 7500 $113.73 Acquired 20135 Direct
2019-07-29 Common Stock S 7500 $526.1403 Disposed 12635 Direct
2019-07-29 Common Stock M 7500 $113.73 Acquired 20135 Direct
2019-07-29 Common Stock S 7500 $526.0854 Disposed 12635 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-29 Non-Qualified Stock Option (right to buy) $113.73 M 7500 Disposed 2021-02-15 Common Stock (7500) Direct
2019-07-29 Non-Qualified Stock Option (right to buy) $113.73 M 7500 Disposed 2021-02-15 Common Stock (7500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 726 Indirect

Footnotes

F1: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019.

F2: The average selling price for the transactions was $526.1403 The shares sold at: $523.00 - $523.99 = 600 shares; $524.00 - $524.99 = 1,176 shares; $525.00 - $525.99 = 1,265 shares; $526.00 to $526.99 = 2,063 shares; $527.00 - $527.99 = 1,560 shares; and $528.00 - $528.99 = 836 shares.

F3: The average selling price for the transactions was $526.0853 The shares sold at: $523.00 - $523.99 = 670 shares; $524.00 - $524.99 = 1,150 shares; $525.00 - $525.99 = 1,081 shares; $526.00 to $526.99 = 2,538 shares; $527.00 - $527.99 = 1,560 shares; and $528.00 - $528.99 = 501 shares.

F4: The Reporting Person's Form 4 filed with the SEC on February 21, 2019 inadvertently overstated the amount of securities beneficially owned following the reported transaction by 78 shares in Column 5 of Table I. This Form 4 reflects an adjustment to Column 5 total to correct the aforementioned error. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported.

F5: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter.